Amrutanjan Health Care Q1 FY27 Results & Earnings Intelligence
AMRUTANJANStructural risk assessment following Q1-FY27 | 30 Jun 26 earnings.
₹106.8 Cr
+8.4% YoY•-30.9% QoQ
₹6.1 Cr
-46.3% YoY•-71.1% QoQ
₹4.4 Cr
-47.5% YoY•-73.0% QoQ
24/ 100
+14 pts QoQ
The Quarter at a Glance
Consolidated Financials| Metric | Q1-FY27 | 30 Jun 26 | Q1-FY26 | 30 Jun 25 | YoY Δ | Q4-FY26 | 31 Mar 26 | QoQ Δ |
|---|---|---|---|---|---|
| Total Revenue / Income | ₹106.8 Cr | ₹98.5 Cr | +8.4% | ₹154.5 Cr | -30.9% |
| Profit Before Tax (PBT) | ₹6.1 Cr | ₹11.3 Cr | -46.3% | ₹21.0 Cr | -71.1% |
| Net Profit (PAT) | ₹4.4 Cr | ₹8.3 Cr | -47.5% | ₹16.2 Cr | -73.0% |
Sources:Official BSE/NSE Disclosures & Financial Filings
Sentinel Executive Summary
Core Earnings Synthesis"Amrutanjan Health Care Limited currently sits within Flagium's Watch category. However, recent periods have introduced early signs of competitive and operating pressure, leverage and funding pressure. Revenue growth remained positive, but profit contraction and triggers like 'Relative Growth Weakness', 'Industrial Margin Stress' increased structural risk. While not currently existential, persistent friction suggests that structural risk is rising."
Amrutanjan Health Care Limited successfully defended its top-line revenue growth, but faced bottom-line compression due to escalating operating costs or margin friction. With 3 active flags, the structural profile reflects temporary margin headwinds despite stable market demand.
🟢 Key Operational & Structural Positives
- ✓Revenue Growth: Quarterly revenue moved +8.4% YoY and -30.9% QoQ, reflecting demand and volume trends.
- ✓Operating Margins: Operating margin moved -389 bps YoY and -1094 bps QoQ to 7.58%.
⚠️ Key Areas of Watch & Margin Pressures
- ⚠Raw material price movement and its impact on operating margins.
- ⚠Working capital efficiency and cash flow conversions.
- ⚠Domestic demand recovery and segment-wise volume growth.
Total Revenue / Income grew +8.4% YoY, but moderated -30.9% QoQ vs Q4-FY26. This divergence typically reflects seasonal lumpiness or elevated base in prior quarters rather than secular deterioration; underlying annual growth remains intact. Similarly, Net Profit (PAT) moderated -73.0% QoQ while maintaining -47.5% YoY.
Flagium Risk Signals
Automated Forensic SignalsRelative Growth Weakness • Industrial Margin Stress • Operating Leverage Stress
Revenue growth consistently lags behind sector median (18.1%).
AMRUTANJAN: EBITDA margin compressed by 10.2 bps YoY and Raw material costs consumed an additional 3.9% of revenue YoY.
Expenses are consistently growing faster than revenues, creating operational pressure.
Capital Allocation & Shareholder Return
DividendBoard approved capital distribution for Q1-FY27
₹2.90 / share
Approved by Board11-Sep-2026
Shareholder Cut-offReported
Earnings BackedWithin 30 Days
Statutory Window🎙️ Amrutanjan Health Care (AMRUTANJAN) Q1 FY27 Concall Intelligence
Management Commentary, Concall Takeaways & Key Discussion Themes
No earnings call transcript was available
for this reporting period.
What to do next
Explore AMRUTANJAN's full structural risk profile — 12Q score trajectory, pillar breakdown, flag history, and peer benchmarking.
View AMRUTANJAN profile →See how Healthcare peers and the broader market are positioned. Identify sector-wide stress or rotation signals.
Open market monitor →Check how this Q1-FY27 | 30 Jun 26 result affects your portfolio's overall risk exposure and concentration.
Review your portfolio →Continue Research
Same Company
📬 Flagium Risk Brief — Track forensic risks on AMRUTANJAN & 3 market anomalies weekly
See a sample issue →Methodology & Regulatory Disclaimer
Flagium AI is an automated financial data analytics platform. Analysis reports are compiled programmatically from public regulatory XBRL submissions (NSE/BSE) for educational and research purposes only. Flagium AI is not registered with SEBI as a Research Analyst or Investment Adviser under SEBI regulations. This evaluation does not constitute investment advice, financial planning, or recommendations to buy, sell, or hold any security.
Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered Investment Adviser before acting on any data presented.